Comprehensive phenotyping of regulatory T cells after liver transplantation. Issue 3 (20th January 2015)

• Record Type: Journal Article
• Authors: Gronert Álvarez, Anna; Fytili, Paraskevi; Suneetha, Pothakamuri V.; Kraft, Anke R. M.; Brauner, Christin; Schlue, Jerome; Krech, Till; Lehner, Frank; Meyer‐Heithuis, Christoph; Jaeckel, Elmar; Klempnauer, Juergen; Manns, Michael P.; Cornberg, Markus; Wedemeyer, Heiner
• Is Part Of: Liver transplantation. Volume 21:Issue 3(2015:Mar.)
• Page Start: 381
• Page End: 395
• Publication Date: 2015-01-20
• Subjects: Liver -- Transplantation -- Periodicals; Liver -- Diseases -- Periodicals; Liver Transplantation -- Periodicals; Foie -- Greffe -- Périodiques; 617.5560592
• DOI: 10.1002/lt.24050
• Languages: English
• ISSNs: 1527-6465

Abstract

Abstract : Regulatory T cells (Tregs) play an important role in controlling alloreactivity after solid organ transplantation, but they may also impair antiviral immunity. We hypothesized that the Treg frequency and the Treg phenotype are altered in hepatitis C virus (HCV)–infected recipients of liver transplantation (LT) with possible prognostic implications. Tregs from 141 individuals, including healthy individuals, LT recipients with or without persistent HCV infections, and nontransplant patients with chronic HCV, were studied. A comprehensive phenotypic analysis was performed with multicolor flow cytometry, which included standard Treg markers [CD4 +, CD25 hi, CD127 –, and FoxP3 + in addition to HLA DR, CCR7, CD45RA, CD62L, CD49d, CD39, ICOS and LAP‐TGFβ stainings. Healthy individuals and LT patients displayed similar Treg frequencies and largely comparable Treg phenotypes, which were stable over time after transplantation. In contrast, Tregs with a CD45RA – CCR7 – effector phenotype were enriched in LT recipients with chronic HCV versus HCV‐negative transplant patients. HCV infection, rather than LT, altered the expression of functional markers on Tregs. A principal component analysis revealed distinct Treg phenotypes in HCV‐infected LT recipients with rejection and patients with recurrent graft HCV. In conclusion, Treg phenotypes are altered in HCV‐infected LT patients. An investigation of Tregs may possibly help to distinguish recurrent HCV from graft rejection. Further functional studies are needed to define the role of Tregs in determining the balance between antiviral and allogenic immunity. Liver Transpl 21:381–395, 2015 . © 2015 AASLD.